(Q44060950)

29 November 2017

title

High-dose methylprednisolone therapy in multiple sclerosis increases serum uric acid levels (English)

1 reference

29 November 2017

0 references

1 reference

Gordana Toncev

1

1 reference

29 November 2017

Biljana Milicic

series ordinal

2

1 reference

29 November 2017

Slavco Toncev

series ordinal

3

1 reference

29 November 2017

Goran Samardzic

series ordinal

4

1 reference

29 November 2017

publication date

1 May 2002

1 reference

Clinical Chemistry and Laboratory Medicine

29 November 2017

published in

1 reference

29 November 2017

volume

40

1 reference

29 November 2017

issue

5

1 reference

29 November 2017

page(s)

505-508

1 reference

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

Towards the physiological function of uric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

The pathology of multiple sclerosis and its evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

Uric acid levels in sera from patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

Monocyte-derived dendritic cells: a potential target for therapy in multiple sclerosis (MS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

The effect of corticosteroids on serum and cerebrospinal fluid nitric oxide levels in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

The role of uric acid in protection against peroxynitrite-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.088

21 January 2018

Identifiers

DOI

10.1515/CCLM.2002.088

1 reference

29 November 2017

1 reference